Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.
However, the EHE has fallen far behind its goal. While Biden has continued the plan, between 2019 and 2022, the number of new ...
Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...
A research group led by Professor Wei Li from the Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Toho ...
Baguio City has been averaging seven new HIV cases monthly since January, while Benguet province reports three cases per ...
As far as affordable ARVs for HIV/AIDS patents are concerned, one recalls a successful civil society movement in South Africa ...
A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination.
Robert F. Kennedy Jr., Donald Trump’s pick to lead the US Department of Health and Human Services, has been vocally anti-pharma. Pharma, Congress, and the courts, though, all get a say.
potentially category-defining anti-PRLR antibody in development for androgenic alopecia Leading AI platform demonstrated breakthrough in successful de novo design of antibody targeting previously ...
The Fiji Medical Association is making an urgent call to the Ministry of Health to declare a HIV outbreak in the country and ...
HIV Latency Reversing Properties in African Plant Nov. 19, 2024 — The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV ...